TY - JOUR
T1 - Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008–2016)
AU - Hirth, Jacqueline M.
AU - Fuchs, Erika L.
AU - Chang, Mihyun
AU - Fernandez, Maria E.
AU - Berenson, Abbey B.
N1 - Funding Information:
E.L. Fuchs is a Scholar supported by a research career development award (K12HD052023: Building Interdisciplinary Research Careers in Women’s Health Program–BIRCWH; Principal Investigator: Berenson) from the Office of Research on Women’s Health (ORWH) , the Office of the Director (OD) , the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health . The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the Research Data Center, the National Center for Health Statistics, or the Centers for Disease Control and Prevention. The sponsors did not have any role in the study design, collection, analysis, and interpretation of the data or any other aspect of this study or manuscript.
Funding Information:
E.L. Fuchs is a Scholar supported by a research career development award (K12HD052023: Building Interdisciplinary Research Careers in Women's Health Program?BIRCWH; Principal Investigator: Berenson) from the Office of Research on Women's Health (ORWH), the Office of the Director (OD), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health. The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the Research Data Center, the National Center for Health Statistics, or the Centers for Disease Control and Prevention. The sponsors did not have any role in the study design, collection, analysis, and interpretation of the data or any other aspect of this study or manuscript.
Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/1/21
Y1 - 2019/1/21
N2 - Background: Human papillomavirus (HPV) vaccination is expected to reduce HPV-related disease and cancer in the US. However, many parents are hesitant to obtain the vaccine for their children. The purpose of this study is to examine how the reasons for refusing the HPV vaccine vary across regions of the US, across time, and by race/ethnicity. Methods: This study used data on 13–17 year old adolescents collected by the National Immunization Survey – Teen (NIS-Teen) annually between 2008 and 2016. We evaluated the frequencies of parents who did not intend to vaccinate their children in the next year among unvaccinated children. Among these non-intenders, we evaluated how reasons for HPV vaccine hesitancy changed across time, by region of the US, and race/ethnicity. Results: The proportion of non-intenders among unvaccinated decreased from 72% in 2010 to 58% in 2016. The most frequent reason for vaccine hesitancy was that parents felt HPV vaccination was not necessary (22.4%), followed by lack of provider recommendation (16.2%), and lack of knowledge (15.6%). Lack of provider recommendation increased in frequency as a reason for HPV vaccine hesitancy until 2012, then decreased in frequency through 2016. Cost was one reason that was elevated in all regions compared to the Northeast. Black non-intenders were less likely to report safety, costs, or their children's fear as reasons for not intending to vaccinate their children compared to white non-intenders. Hispanic non-intenders were more likely to report lack of knowledge and that the vaccine is not a school requirement as reasons not to vaccinate their children compared to white non-intenders. Conclusions: National advocacy for improving provider recommendation for HPV vaccination likely contributed to a sharp decline in HPV vaccine hesitancy due to lack of provider recommendation. Results indicate the need for multifaceted interventions to increase HPV vaccination.
AB - Background: Human papillomavirus (HPV) vaccination is expected to reduce HPV-related disease and cancer in the US. However, many parents are hesitant to obtain the vaccine for their children. The purpose of this study is to examine how the reasons for refusing the HPV vaccine vary across regions of the US, across time, and by race/ethnicity. Methods: This study used data on 13–17 year old adolescents collected by the National Immunization Survey – Teen (NIS-Teen) annually between 2008 and 2016. We evaluated the frequencies of parents who did not intend to vaccinate their children in the next year among unvaccinated children. Among these non-intenders, we evaluated how reasons for HPV vaccine hesitancy changed across time, by region of the US, and race/ethnicity. Results: The proportion of non-intenders among unvaccinated decreased from 72% in 2010 to 58% in 2016. The most frequent reason for vaccine hesitancy was that parents felt HPV vaccination was not necessary (22.4%), followed by lack of provider recommendation (16.2%), and lack of knowledge (15.6%). Lack of provider recommendation increased in frequency as a reason for HPV vaccine hesitancy until 2012, then decreased in frequency through 2016. Cost was one reason that was elevated in all regions compared to the Northeast. Black non-intenders were less likely to report safety, costs, or their children's fear as reasons for not intending to vaccinate their children compared to white non-intenders. Hispanic non-intenders were more likely to report lack of knowledge and that the vaccine is not a school requirement as reasons not to vaccinate their children compared to white non-intenders. Conclusions: National advocacy for improving provider recommendation for HPV vaccination likely contributed to a sharp decline in HPV vaccine hesitancy due to lack of provider recommendation. Results indicate the need for multifaceted interventions to increase HPV vaccination.
KW - HPV vaccination
KW - Reasons for vaccine hesitancy
KW - Vaccine disparities
KW - Vaccine hesitancy
UR - http://www.scopus.com/inward/record.url?scp=85058796254&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058796254&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2018.12.017
DO - 10.1016/j.vaccine.2018.12.017
M3 - Article
C2 - 30580838
AN - SCOPUS:85058796254
SN - 0264-410X
VL - 37
SP - 595
EP - 601
JO - Vaccine
JF - Vaccine
IS - 4
ER -